1-4 of 4
Julia Catini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Outcomes for Patients with Light Chain (AL) Amyloidosis: Analysis of a Large US Claims Database

Genevieve Lyons, Jeffrey Thompson, Isabelle Lousada, Mathew S Maurer, Julia Catini, Richa Manwani
Journal: Blood
Blood (2023) 142 (Supplement 1): 6748.
https://doi.org/10.1182/blood-2023-187073
Published: 2023
Journal Articles

Safety and Tolerability of Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia Therapy in Patients with Light-Chain Amyloidosis: 24-Month Results of a Phase 2 Study

Jason Valent, Michaela Liedtke, Jeffrey A. Zonder, Richa Manwani, Chandrasekhar Udata, Juliana Ianus, John Tripptree, Julia Catini, Candida Cristina Quarta
Journal: Blood
Blood (2023) 142 (Supplement 1): 540.
https://doi.org/10.1182/blood-2023-186515
Published: 2023
Journal Articles

1-Year Results from a Phase 2 Study to Determine Safety and Tolerability of Treating Patients with Light-Chain (AL) Amyloidosis with Cael-101, an Anti-Amyloid Monoclonal Antibody, Combined with Anti-Plasma Cell Dyscrasia

Jason Valent, Michaela Liedtke, Jeffrey A. Zonder, Mark Tulchinskiy, Chandrasekhar Udata, Girly Ramirez, Kate Szymaniak, Julia Catini, Candida Cristina Quarta
Journal: Blood
Blood (2022) 140 (Supplement 1): 10127–10128.
https://doi.org/10.1182/blood-2022-162597
Published: 2022
Journal Articles

Evaluation of the Path to Diagnosis and Time to Treatment in Patients with Light-Chain Amyloidosis Using the Komodo Claims Database

Julia Catini, Quan Doan, Jennifer Evans, Andrew Rava, Thomas Defay, Guillermo Del Angel, Megan Teynor, Candida Cristina Quarta, Mathew S. Maurer, Isabelle Lousada
Journal: Blood
Blood (2022) 140 (Supplement 1): 4330–4331.
https://doi.org/10.1182/blood-2022-162694
Published: 2022